0001038133-16-000201.txt : 20160304 0001038133-16-000201.hdr.sgml : 20160304 20160304181129 ACCESSION NUMBER: 0001038133-16-000201 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160302 FILED AS OF DATE: 20160304 DATE AS OF CHANGE: 20160304 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HESKA CORP CENTRAL INDEX KEY: 0001038133 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 770192527 STATE OF INCORPORATION: DE FISCAL YEAR END: 0214 BUSINESS ADDRESS: STREET 1: 3760 ROCKY MOUNTAIN AVENUE CITY: LOVELAND STATE: CO ZIP: 80538 BUSINESS PHONE: 9704937272 MAIL ADDRESS: STREET 1: 3760 ROCKY MOUNTAIN AVENUE CITY: LOVELAND STATE: CO ZIP: 80538 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: McGinley Michael J CENTRAL INDEX KEY: 0001392225 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-22427 FILM NUMBER: 161486446 MAIL ADDRESS: STREET 1: 3760 ROCKY MOUNTAIN AVENUE CITY: LOVELAND STATE: CO ZIP: 80538 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2016-03-02 0 0001038133 HESKA CORP HSKA 0001392225 McGinley Michael J 3760 ROCKY MOUNTAIN AVENUE LOVELAND CO 80538 0 1 0 0 Presi, Biologic. & Pharm. Common Stock 2016-03-02 4 A 0 14896 0 A 30855 D Common Stock 2016-03-02 4 F 0 757 33.64 D 30098 D Includes 12,863 shares issued on March 17, 2015 subject to a performance-based restricted stock grant for which the underlying performance condition has been achieved but the shares have not yet vested and 2,033 shares issued on March 17, 2015 subject to a performance-based restricted stock grant related to Heska Corporation's 2015 Management Incentive Plan for which the underlying performance condition has been achieved and the shares have vested. Shares withheld to fulfill minimum statutory withholding obligations. By: Jason A. Napolitano For: Michael McGinley 2016-03-04